The ENDOLEASE project, a spin-off initiative from University Hospital Würzburg, aims to revolutionize drug delivery and minimize unwanted side effects. Conventional systemic drug administration often causes adverse effects in other organs, reducing its overall efficacy. ENDOLEASE addresses this issue by developing a resorbable implant that is inserted directly into the artery. This implant delivers active substances straight into the bloodstream, ensuring targeted and effective therapy, particularly for conditions like heart attacks, strokes, and cancer.
Company Details
- Employees
- 3
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://endolease.de
- Keywords
- Marktbreit.
Endolease-Systems Questions
Endolease-Systems's website is https://endolease.de
Endolease-Systems's LinkedIn profile is https://www.linkedin.com/company/endolease-systems
Endolease-Systems has
3 employees.
View email and phone details for 3
employees at Endolease-Systems.
Endolease-Systems's industry is
Medical Equipment Manufacturing
Endolease-Systems's top competitors are
Fived,
Vasc-On-Demand,
Rivercyte,
Cellcircle,
Strokecap,
Rocketmind,
Lama Consulting,
Biofabrication Würzburg,
Looppack,
Refacto.
Endolease-Systems's categories are Medical Equipment Manufacturing
